Skip to content

13F-HR filed by NORTH TIDE CAPITAL, LLC

NORTH TIDE CAPITAL, LLC filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-14, with 12 holding rows worth $449,407,000.

Accession
0001140361-17-031616
Filed
2017-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2017

A holdings report, 12 entries on the cover page, a total value of $449,407,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $449,407,000 with VALUE read as thousands by filing date, 13F file number 028-15326. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TIVITY HEALTH INC88870R102COM2,500,000$99,625,000thousands by filing date
SELECT MED HLDGS CORP81619Q105COM5,000,000$76,750,000thousands by filing date
Gilead Sciences,Inc.375558103COM1,000,000$70,780,000thousands by filing date
MYLAN NVN59465109SHS EURO1,000,000$38,820,000thousands by filing date
ENDO INTL PLCG30401106SHS3,000,000$33,510,000thousands by filing date
SUPERVALU INC868536103COM10,000,000$32,900,000thousands by filing date
MCKESSON CORP COM58155Q103Stock150,000$24,681,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock300,000$22,656,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock1,000,000$19,340,000thousands by filing date
IMPAX LABORATORIES INC45256B101COM1,000,000$16,100,000thousands by filing date
BIOSCRIP INC09069N108COM3,000,000$8,145,000thousands by filing date
VIVUS INC928551100COM5,000,000$6,100,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-17-031616this filing2017-08-14acceptance time not in the bulk data set